References
- Djang DS, Janssen MJ, Bohnen N, et al. SNM practice guideline for dopamine transporter imaging with 123I-ioflupane SPECT 1.0. J Nucl Med. 2012;53:154-163.
- DaTscan™ (Ioflupane I-123 injection) prescribing information. GE Healthcare. April, 2011.
- Parkinson’s Disease Foundation. DaTscan for Parkinson's: what does it mean? Jan 20, 2011. www.pdf.org/en/science_news/release/pr_1295578745. Accessed August 7, 2013.
- Berendse HW, Ponsen MM. Diagnosing premotor Parkinson's disease using a two-step approach combining olfactory testing and DAT SPECT imaging. Parkinsonism Relat Disord. 2009;15(Suppl 3):S26-30.
- Shulman LE, Katzel LI, Ivey FM, et al. Randomized clinical trial of 3 types of physical exercise for patients with Parkinson disease. JAMA Neurol. 2013;70:183-190.
- Suchowersky O, Gronseth G, Perlmutter J, et al. Practice parameter: neuroprotective strategies and alternative therapies for Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2006;66:976-982.
- Li E, Harmer P, Fitzgerald K, et al. Tai chi and postural stability in patients with Parkinson's disease. N Engl J Med. 2012;366:511-519.
- de Dreu MJ, van der Wilk AS, Poppe E, Kwakkel G, van Wegen EE. Rehabilitation, exercise therapy and music in patients with Parkinson's disease: a meta-analysis of the effects of music-based movement therapy on walking ability, balance and quality of life. Parkinsonism Relat Disord. 2012;18(Suppl 1):S114-S119.
- Hackney ME, Earhart GM. Effects of dance on gait and balance in Parkinson's disease: a comparison of partnered and nonpartnered dance movement. Neurorehabil Neural Repair. 2010;24:384-392.
- Ahlskog JE. Does vigorous exercise have a neuroprotective effect in Parkinson disease? Neurology. 2011;77:288-294.
- Ellis T, Boudreau JK, DeAngelis TR, et al. Barriers to exercise in people with Parkinson disease. Phys Ther. 2013;93:628-636.
- Snijders AH, Toni I, Ruzicka E, Bloem B. Bicycling breaks the ice for freezers of gait. Mov Disord. 2011;26:367-371.
- Lyons KE, Pahwa R. Diagnosis and initiation of treatment in Parkinson’s disease. Int J Neurosci. 2011;121:27-36.
- Ecker D, Unrath A, Kassubek J, Sabolek M. Dopamine agonists and their risk to induce psychotic episodes in Parkinson's disease: a case-control study. BMC Neurol. 2009;10:9-23.
- Ng DC. Topics in primary care medicine: Parkinson’s disease diagnosis and treatment. West J Med. 1996;165:234-240.
- Lyons KE, Pahwa R. The impact and management of nonmotor symptoms of Parkinson's disease. Am J Manag Care. 2011;17(Suppl 12):S308-S314.
- Dall TM, Storm MV, Chakrabarti R, et al. Supply and demand analysis of the current and future US neurology workforce. Neurology. 2013;81:470-478.
|